- Accueil >
- Publications >
- Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer inBRCA1/BRCA2mutation carriers
Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer inBRCA1/BRCA2mutation carriers
Auteurs
Lucie Bignon, Jean-Pierre Fricker, Catherine Nogues, Emmanuelle Mouret-Fourme, Dominique Stoppa-Lyonnet, Olivier Caron, Alain Lortholary, Laurence Faivre, Christine Lasset, Veronique Mari, Paul Gesta, Laurence Gladieff, Akila Hamimi, Thierry Petit, Michel Velten